Literature DB >> 31785340

Expression and purification of codon-optimized cre recombinase in E. coli.

Srividya D1, Anil H Shyam Mohan2, Saroja Narsing Rao3.   

Abstract

The presence of antibiotic resistance genes in genetically modified bacteria raises a regulatory concern in the production of therapeutic proteins and additionally reduces the number of plasmids available for propagation in a cell. Cre recombinase from bacteriophage P1, involved in Cre/loxP mechanism is one of the widely used systems for selectable marker gene removal. We have overexpressed codon-optimized cre gene in pColdIV and pET28a(+) vector systems and purified His6-Cre recombinase by immobilized metal affinity chromatography. N-terminal His6 tagged Cre recombinase obtained was approximately 26 fold purified and promoted the site-specific recombination of two loxP sites of linearized pLox2+ vector allowing the excision of a re-circularized plasmid and a short stretch of DNA containing the recombined loxP site. The results of the expression using two vectors, purification and activity assessment of His6 tagged Cre recombinase is presented here.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cre recombinase; Cre/loxP; Immobilised metal affinity chromatography; In-fusion cloning reaction; pColdIV vector; pET28a(+) vector

Year:  2019        PMID: 31785340     DOI: 10.1016/j.pep.2019.105546

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  2 in total

1.  Gain of Spontaneous clpX Mutations Boosting Motility via Adaption to Environments in Escherichia coli.

Authors:  Bingyu Li; Chaofan Hou; Xian Ju; Yong Feng; Zhi-Qiang Ye; Yunzhu Xiao; Mingyao Gu; Chunxiang Fu; Chaoliang Wei; Conghui You
Journal:  Front Bioeng Biotechnol       Date:  2021-11-24

2.  Development of a rabies virus-based retrograde tracer with high trans-monosynaptic efficiency by reshuffling glycoprotein.

Authors:  Fan Jia; Li Li; Haizhou Liu; Pei Lv; Xiangwei Shi; Yang Wu; Chen Ling; Fuqiang Xu
Journal:  Mol Brain       Date:  2021-07-08       Impact factor: 4.041

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.